Trials / Sponsors / China Meitan General Hospital
China Meitan General Hospital
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Chimeric Switch Receptor Modified T Cells for Patients With PD-L1+ Recurrent or Metastatic Malignant Tumors Recurrent PD-L1+ Malignant Tumors, Metastatic PD-L1+ Malignant Tumors | Phase 1 | 2016-08-01 |
| Unknown | Anti-mesothelin CAR T Cells for Patients With Recurrent or Metastatic Malignant Tumors Mesothelin Positive Tumors | Phase 1 | 2016-08-01 |
| Completed | Chemotherapy Combined With CIK Treating Colon Cancer Colorectal Cancer, Cytokine-induced Killer Cells, Postoperative Complications | Phase 4 | 2012-05-06 |